Travere Therapeutics Q3 2026 Earnings Preview
- Travere Therapeutics (TVTX) is scheduled to announce Q3 earnings results on Monday, November 2nd, after market close.
- The consensus EPS Estimate is $0.42 (-28.8% Y/Y) and the consensus Revenue Estimate is $195.29M (+18.4% Y/Y).
- Over the last 2 years, TVTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 3 downward. Revenue estimates have seen 12 upward revisions and 1 downward.
Recommended For You
Create Your Free Account to Keep Reading
Get the confidence to navigate an uncertain market with free breaking news and stock alerts.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.